Source:http://linkedlifedata.com/resource/pubmed/id/11520208
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
18
|
pubmed:dateCreated |
2001-8-24
|
pubmed:abstractText |
Using a solution-phase parallel synthesis strategy, a series of non-peptide somatostatin analogues were prepared, and their binding affinities to the five human somatostatin receptor subtypes (sst(1-5)) were determined. Imidazolyl derivatives 2 were found to bind with moderate affinity but with high selectivity to the sst(3) receptor subtype. Further modifications of these structures led to a more potent class of ligands, the tetrahydro-beta-carboline derivatives 4. Among these, compounds 4k (BN81644) and 4n (BN81674) bind selectively and with high affinity to the sst(3) receptor subtype (K(i) = 0.64 and 0.92 nM, respectively). Furthermore, 4k and 4n reverse the inhibition of cyclic AMP accumulation induced by 1 nM somatostatin via sst(3) receptors, with IC(50) = 2.7 and 0.84 nM, respectively. The most potent compound 4n was shown to be a competitive antagonist of human sst(3) receptors by increasing the EC(50) of SRIF-14-mediated inhibition of cAMP accumulation with a K(B) of 2.8 nM (where K(B) is the concentration of antagonist that shifts the agonist dose-response 2-fold). These new derivatives are, to our knowledge, the first potent and highly selective non-peptide human sst(3) antagonists known and, as such, are useful tools for investigating the physiological role of sst(3) receptors.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Carbolines,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclic AMP,
http://linkedlifedata.com/resource/pubmed/chemical/Ligands,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Somatostatin,
http://linkedlifedata.com/resource/pubmed/chemical/Somatostatin,
http://linkedlifedata.com/resource/pubmed/chemical/somatostatin receptor type 1
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0022-2623
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
30
|
pubmed:volume |
44
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2990-3000
|
pubmed:dateRevised |
2005-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11520208-Animals,
pubmed-meshheading:11520208-CHO Cells,
pubmed-meshheading:11520208-Carbolines,
pubmed-meshheading:11520208-Cricetinae,
pubmed-meshheading:11520208-Cyclic AMP,
pubmed-meshheading:11520208-Humans,
pubmed-meshheading:11520208-Ligands,
pubmed-meshheading:11520208-Radioligand Assay,
pubmed-meshheading:11520208-Receptors, Somatostatin,
pubmed-meshheading:11520208-Somatostatin,
pubmed-meshheading:11520208-Structure-Activity Relationship
|
pubmed:year |
2001
|
pubmed:articleTitle |
Identification of potent non-peptide somatostatin antagonists with sst(3) selectivity.
|
pubmed:affiliation |
Institut Henri Beaufour, 5 Avenue du Canada, F-91966 Les Ulis, France. lydie.poitout@beaufour-ipsen.com
|
pubmed:publicationType |
Journal Article
|